openPR Logo
Press release

Comprehensive Anemia In Elderly Market Insights: Forecasting Size, Growth, and Competitive Trends from 2025 to 2034

03-28-2025 09:09 AM CET | Health & Medicine

Press release from: The Business Research Company

Anemia In Elderly Market Share

Anemia In Elderly Market Share

What market dynamics are playing a key role in accelerating the growth of the anemia in elderly market?
The expansion of the anemia in the elderly market is expected to be powered by the growing elderly population. This elderly group is defined as an increasingly large portion or count of individuals who are 65 or older in a specified society or on a global scale. Several factors contribute to this upward trend in the elderly population including longer life expectancy, lower birth rates, and the aging of sizeable demographic groups. A larger elderly population naturally leads to an increased occurrence of age-related and chronic conditions, with anemia being a prominent issue among the elderly. The need for diagnosis, management, and treatment of anemia thus increases, spurring on market growth. In 2024, the Office for National Statistics (ONS), a government organization based in the UK, reported that the number of people aged 65 or over in the UK had grown from 11 million in 2021 to 12.7 million in 2022. For this reason, it can be deduced that the escalating elderly population is a driving factor for the growth of the anemia in elderly market.

Get Your Anemia In Elderly Market Report Here:
https://www.thebusinessresearchcompany.com/report/anemia-in-elderly-global-market-report

How will the growth rate of the anemia in elderly market shape industry trends by 2034?
In recent times, the market size of anemia in the elderly has experienced substantial growth. The market size is projected to rise from $2.75 billion in 2024 to about $3.02 billion by 2025, boasting a compound annual growth rate (CAGR) of 9.7%. Factors contributing to growth in the previous phases include nutritional deficiencies, chronic illnesses, inflammation, disorders of bone marrow, and blood loss.

The market size of anemia in the elderly is projected to witness a robust growth in the coming years, reaching $4.32 billion by 2029 with a compound annual growth rate (CAGR) of 9.3%. The expansion during the forecast period can be linked to factors such as an aging population, an increase in chronic illnesses, advancements in diagnostics, growing health consciousness, and better accessibility to treatment. The forecast period will also see major trends like diagnostics powered by artificial intelligence, wearable health trackers, sophisticated blood testing tools, the incorporation of telehealth, and custom treatment plans.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20711&type=smp

What trends are poised to drive the future success of the anemia in elderly market?
Leading businesses in the anemia among the elderly market are concentrating on technological innovations, such as bespoke treatments, to make treatment procedures more efficient, enhance patient results, minimize adverse reactions, and improve overall healthcare productivity. Individualized treatments are medical procedures tailored to the specific attributes of each patient. For example, in March 2024, Cadila Pharmaceuticals, a pharmaceutical company based in India, unveiled Redshot FCM, a ground-breaking iron injection intended to treat iron deficiency anemia in patients struggling with oral iron intolerance. Redshot FCM, an intravenous preparation, provides sufficient iron and highlights an incredible safety record. This injection uses an innovative Ferric Carboxymaltose recipe that boosts iron supply and absorption. By creating personalized treatments that consider each patient's unique profile, Redshot FCM illustrates a commitment to enhancing healthcare and improving treatment outcomes for iron deficiency anemia.

Which primary segments of the anemia in elderly market are driving growth and industry transformations?
The anemia in elderly market covered in this report is segmented -

1) By Product Type: Tablets, Injectable
2) By Treatment: Iron Supplements, Erythropoietin Or Erythrocyte-Stimulating Agents, Vitamin B12 Supplements, Folic Acid Supplements
3) By Route Of Administration: Oral, Parenteral
4) By End User: Hospital pharmacy, Online Pharmacy, Retail pharmacy

Subsegments:
1) By Tablets: Iron Supplements, Vitamin B12 Supplements, Folic Acid Tablets, Erythropoiesis-Stimulating Agents (ESAs) Tablets
2) By Injectable: Iron Injections, Vitamin B12 Injections, Erythropoiesis-Stimulating Agents (ESAs) Injections, Folic Acid Injections

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20711

Which geographical regions are pioneering growth in the anemia in elderly market?
North America was the largest region in the anemia in elderly market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anemia in elderly market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the influential players reshaping the anemia in elderly market landscape?
Major companies operating in the anemia in elderly market are Johnson & Johnson, Roche Holding AG, Merck & Co Inc, Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, Takeda Pharmaceutical Company Limited, Amgen Inc, Japan Tobacco Inc, Fresenius Medical Care AG, Teva Pharmaceutical Industries Ltd, Sandoz International GmbH, CSL Limted, Daiichi Sankyo Company Limited, Amag Pharmaceuticals, Akebia Therapeutics Inc, Pharmacosmos A/S, Rockwell Medical Inc, Bioage Labs Inc, Shield Therapeutics Plc, MegaPro Biomedical Co Ltd

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20711&type=smp

What Is Covered In The Anemia In Elderly Global Market Report?

•Market Size Forecast: Examine the anemia in elderly market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the anemia in elderly market for a structured understanding.
•Key Players Overview: Analyze major players in the anemia in elderly market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the anemia in elderly market.
•Segment Contributions: Evaluate how different segments drive overall growth in the anemia in elderly market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the anemia in elderly market.
•Industry Challenges: Identify potential risks and obstacles affecting the anemia in elderly market.
•Competitive Landscape: Review strategic developments in the anemia in elderly market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Comprehensive Anemia In Elderly Market Insights: Forecasting Size, Growth, and Competitive Trends from 2025 to 2034 here

News-ID: 3944164 • Views:

More Releases from The Business Research Company

Leading Companies Solidify Their Presence in the Silicone Structural Glazing Market
Leading Companies Solidify Their Presence in the Silicone Structural Glazing Mar …
The silicone structural glazing market is positioned for significant expansion in the coming years, driven by advances in building technology and increased environmental awareness. This sector is evolving rapidly as demand grows for more energy-efficient and aesthetically appealing architectural solutions. Let's explore the market's current size, key players, emerging trends, and the main segments that are shaping its future. Silicone Structural Glazing Market Value Forecast Through 2030 The market for silicone
Future Prospects: Key Trends Shaping the Self-Healing Concrete Market up to 2030
Future Prospects: Key Trends Shaping the Self-Healing Concrete Market up to 2030
The self-healing concrete market is capturing significant attention as innovations and sustainability demands rise in construction. This sector is set to experience remarkable growth due to advancements in materials and technology, shaping the future of durable and intelligent infrastructure solutions. Let's explore the market's size, key players, emerging trends, and segment outlook to understand its trajectory. Projected Market Size and Growth Prospects for the Self-Healing Concrete Market The self-healing concrete market
Analysis of Key Market Segments Driving the ROS-Based Robot Industry
Analysis of Key Market Segments Driving the ROS-Based Robot Industry
The ROS-based robot market is positioned for substantial growth as robotics technology continues to advance rapidly. With increasing innovation in software, hardware, and AI integration, this sector is set to transform multiple industries by 2030. Below, we explore the market's future size, leading companies, key trends, and segmentation details to understand its evolving landscape. Projected Market Size and Expansion of the ROS-Based Robot Market The ROS-based robot market is anticipated to
Global Trends Overview: The Rapid Evolution of the Robotic Panelized Home Builder Market
Global Trends Overview: The Rapid Evolution of the Robotic Panelized Home Builde …
The robotic panelized home builder market is positioned for impressive growth in the coming years as automation and robotics increasingly transform construction processes. Driven by technological advancements and expanding prefab housing projects, this market is set to reshape how homes are built with greater speed and efficiency. Let's explore the market's size, leading companies, emerging trends, and key segments that are shaping its future. Strong Growth Forecast for the Robotic Panelized

All 5 Releases


More Releases for Anemia

Chemotherapy-Induced Anemia Market Forecast by Type Mild Moderate Severe and Lif …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Chemotherapy-Induced Anemia Market- (By Type of Anemia (Mild Anemia, Moderate Anemia, Severe Anemia, Life-Threatening Anemia), By Treatment Type (RBC Transfusion, Erythropoiesis-stimulating agents (ESAs), Iron Supplementation), By Drug Type (Epogen Injection, Procrit Injection, Androxy Oral, Aranesp Injection, Epoetin Alfa Injection, and Others), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)), By Region, Trends, Industry Competition
Rising Cancer And Anemia Cases Propel Growth In Chemotherapy-Induced Anemia Mark …
The Chemotherapy-Induced Anemia Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Chemotherapy-Induced Anemia Market Size During the Forecast Period? The Chemotherapy-Induced Anemia Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This
Iron Deficiency Anemia Market Analysis 2034 | Iron Deficiency Anemia Therapies, …
As per DelveInsight, the Iron Deficiency Anemia Market is anticipated to grow immensely in the coming years owing to the launch of upcoming therapies and the increase in the incident population of Iron Deficiency Anemia in the 7MM. DelveInsight's "Iron Deficiency Anemia Market Insights, Epidemiology, and Market Forecast 2034 [https://www.delveinsight.com/report-store/iron-deficiency-anemia-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Iron Deficiency Anemia market size,
Aplastic Anemia Treatment Market - Shaping the Future of Aplastic Anemia Health: …
Newark, New Castle, USA: The "Aplastic Anemia Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Aplastic Anemia Treatment Market: https://www.growthplusreports.com/report/aplastic-anemia-treatment-market/8435 This latest report researches the industry structure,
Anemia Drugs Market 2018 Grow at CAGR of 8.4% to Reach USD 34.7 Billion | By Uni …
Market Research Future Published a Prime research Report on “Global Anemia Drugs Market Research Report - Forecast to 2022” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022 Global Anemia Drugs Market - Segments Global anemia drugs market has been segmented on the basis of anemia type which comprises iron deficiency anemia, sickle cell anemia, aplastic anemia, hemolytic anemia pernicious anemia and others. On the basis of route of administration;
Anemia in Chronic Kidney Disease (Renal Anemia) - Industry Analysis, Trends, and …
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Anemia in Chronic Kidney Disease Pipeline Review, H1 2017” to its report offerings. The report provides an overview of the Anemia in Chronic Kidney Disease (Renal Anemia) (Hematological Disorders) pipeline landscape. Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1196648 Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2017,